These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1819729)

  • 21. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis.
    Soliman A; Michelsen KS; Karahashi H; Lu J; Meng FJ; Qu X; Crother TR; Rabizadeh S; Chen S; Caplan MS; Arditi M; Jilling T
    PLoS One; 2010 Oct; 5(10):e15044. PubMed ID: 20976181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for platelet-activating factor in asthma.
    Chung KF; Barnes PJ
    Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental susceptibility to intestinal injury by platelet-activating factor in the newborn rat.
    Bhatia AM; Ramos CT; Scott SM; Musemeche CA
    J Invest Surg; 1996; 9(5):351-8. PubMed ID: 8951658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: effect of cycloheximide.
    Wang H; Tan XD; Qu XW; Chang H; Remick DG; Gonzalez-Crussi F; Hsueh W
    Pediatr Res; 1997 Nov; 42(5):597-603. PubMed ID: 9357930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
    Saumweber DM; Bergmann R; Gokel M; Brecht HM; Hammer C
    Transplant Proc; 1991 Feb; 23(1 Pt 1):576-8. PubMed ID: 1990613
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats.
    Caplan MS; Hedlund E; Hill N; MacKendrick W
    Gastroenterology; 1994 Feb; 106(2):346-52. PubMed ID: 8299901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor in infants at risk for necrotizing enterocolitis.
    Rabinowitz SS; Dzakpasu P; Piecuch S; Leblanc P; Valencia G; Kornecki E
    J Pediatr; 2001 Jan; 138(1):81-6. PubMed ID: 11148517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730.
    Hilliquin P; Natour J; Aissa J; Guinot P; Laoussadi S; Benveniste J; Menkes CJ; Arnoux B
    Ann Rheum Dis; 1995 Feb; 54(2):140-3. PubMed ID: 7702404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis.
    Amer MD; Hedlund E; Rochester J; Caplan MS
    Biol Neonate; 2004; 85(3):159-66. PubMed ID: 14646336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis.
    Caplan MS; Lickerman M; Adler L; Dietsch GN; Yu A
    Pediatr Res; 1997 Dec; 42(6):779-83. PubMed ID: 9396557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
    Carter MB; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 1996 Feb; 60(2):403-8. PubMed ID: 8598677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor.
    De Plaen IG; Tan XD; Chang H; Wang L; Remick DG; Hsueh W
    Br J Pharmacol; 2000 Jan; 129(2):307-14. PubMed ID: 10694237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis.
    Akisu M; Küllahçioğlu Girgin F; Baka M; Hüsseyinov A; Kültürsay N
    Eur J Pediatr Surg; 2001 Jun; 11(3):167-72. PubMed ID: 11475112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
    Kempfert C; Brandt R; Siewert B; Kanowski U; Oddoy A
    Pneumologie; 1991 Oct; 45(10):799-803. PubMed ID: 1758848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis.
    Caplan MS; Sun XM; Hseuh W; Hageman JR
    J Pediatr; 1990 Jun; 116(6):960-4. PubMed ID: 2348301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.
    Gonzalez-Crussi F; Hsueh W
    Am J Pathol; 1983 Jul; 112(1):127-35. PubMed ID: 6859226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.